1532517-95-5 Usage
Uses
Used in Pharmaceutical Synthesis:
5-bromo-3-fluoro-2-nitropyridine is used as a key intermediate for the production of various pharmaceuticals. Its unique structure and reactivity allow for the creation of a wide range of medicinal compounds, contributing to the development of new drugs.
Used in Agrochemical Production:
In the agrochemical industry, 5-bromo-3-fluoro-2-nitropyridine serves as an essential building block for the synthesis of various agrochemicals. Its properties enable the development of effective products for crop protection and enhancement of agricultural yields.
Used in Organic Chemistry Research:
5-bromo-3-fluoro-2-nitropyridine is utilized as a research tool in organic chemistry. Its interesting chemical properties and potential applications make it valuable for studying reaction mechanisms and exploring new areas in chemical science.
Used in Material Science:
5-bromo-3-fluoro-2-nitropyridine also finds application in material science, where its unique structure can be employed to develop new materials with specific properties. This can include the creation of advanced materials for various industrial applications.
Overall, 5-bromo-3-fluoro-2-nitropyridine is a multifaceted chemical entity with broad applications across different fields, from medicine to material science, underpinning its importance in modern chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1532517-95-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,3,2,5,1 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1532517-95:
(9*1)+(8*5)+(7*3)+(6*2)+(5*5)+(4*1)+(3*7)+(2*9)+(1*5)=155
155 % 10 = 5
So 1532517-95-5 is a valid CAS Registry Number.
1532517-95-5Relevant articles and documents
CERTAIN PROTEIN KINASE INHIBITORS
-
, (2017/12/27)
Provided are certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
CERTAIN PROTEIN KINASE INHIBITOR
-
Paragraph 364; 365, (2017/01/09)
Provided are certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
BIARYL-CONTAINING COMPOUNDS AS INVERSE AGONISTS OF ROR-GAMMA RECEPTORS
-
Paragraph 00439-00440, (2014/01/18)
The present invention relates to biaryl-containing inverse agonists of ROR-gamma receptors. The invention also provides pharmaceutical compositions comprising these biaryl- containing inverse agonists, and methods of modulating ROR-gamma receptors using these inverse agonists. Also provided are methods of using biaryl-containing inverse agonists to treat ROR-gamma mediated diseases.
